Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Hyo-Jung Song"'
Autor:
Isabel Hyo Jung Song, Cameron Paczek
Publikováno v:
2023 IEEE World Engineering Education Conference (EDUNINE).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::427bcad56facc2d47dedf9133d36ff5d
https://doi.org/10.1109/edunine57531.2023.10102893
https://doi.org/10.1109/edunine57531.2023.10102893
Autor:
Wiam Boumaazi, Isabel Hyo Jung Song
Publikováno v:
2022 13th International Conference on Computing Communication and Networking Technologies (ICCCNT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcd280867716d4dce0d109508c89a923
https://doi.org/10.1109/icccnt54827.2022.9984533
https://doi.org/10.1109/icccnt54827.2022.9984533
Autor:
Hyowon Lee, C. Justin Lee, Siwon Kim, Sang-Wook Kim, Sang Ryong Jeon, Soo Jin Oh, Min-Ho Nam, Jun Young Heo, Jiwon Choi, Sun Jun Park, Hyung Ho Yoon, Hyo Jung Song, Jong Hyun Park, Ki Duk Park, Heeyoung An, Bo Ko Jang, Doo-Wan Cho, Su-Cheol Han, Young-Su Yang, Hyeon Jeong Kim
Publikováno v:
Neurotherapeutics
Monoamine oxidase-B (MAO-B) is a well-established therapeutic target for Parkinson’s disease (PD); however, previous clinical studies on currently available irreversible MAO-B inhibitors have yielded disappointing neuroprotective effects. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c8d5238ee55e8f326fa5df429e9ef7
https://doi.org/10.1007/s13311-021-01097-4
https://doi.org/10.1007/s13311-021-01097-4
Publikováno v:
Diabetes. 71
G protein-coupled receptor 40 (GPR40) , also known as free fatty acid receptor 1 (FFA1/FFAR1) , is expressed primarily on pancreatic β-cells and induces insulin secretion only at high glucose levels, making it a promising target for type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f300c5af25580cdf02c72dba1e346bee
https://doi.org/10.2337/db22-112-lb
https://doi.org/10.2337/db22-112-lb
Autor:
Sally Mostafa, Isabel Hyo Jung Song, Ahmed A. Metwally, Nicolas Strauli, Nehemiah Sewde, Michel Friesenhahn, Maxime Usdin, Xiaoming Jia
Publikováno v:
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc15c278838a986ac2c9768593b49843
https://doi.org/10.1109/bibm52615.2021.9669665
https://doi.org/10.1109/bibm52615.2021.9669665
Autor:
Haengjin Song, Chorong Shin, Hyun-Jung Kwak, Jongmin Yoon, Hyo-Jung Song, Eunhye Jang, Kyungmi An, In-Gyu Je, Don-Gil Lee, Jung Ho Kim, Seolhee Lee, Dahae Hong, Jisu Kim, Chang-Hee Hong, Yearin Jun
Publikováno v:
Diabetes. 70
G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1), a clinically validated anti-diabetes target, enhances insulin secretion in type 2 diabetes. It is known that the effect of glucose-stimulated insulin secretion (GSIS) in pancreatic β cells is mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a69e891cae97c17e3dcdf5a4430904d7
https://doi.org/10.2337/db21-122-lb
https://doi.org/10.2337/db21-122-lb
Autor:
In-Gyu Je, Seolhee Lee, Eunhye Jang, Jongmin Yoon, Kyungmi An, Yearin Jun, Don-Gil Lee, Haengjin Song, Hyun-Jung Kwak, Hyo-Jung Song, Dahae Hong, Jisu Kim, Jung Ho Kim, Chang-Hee Hong, Chorong Shin
Publikováno v:
Diabetes. 70
GPR40 has been considered a potential therapeutic target for type 2 diabetes because activation of GPR40 stimulates insulin secretion when glucose levels increased. Fasiglifam, a GPR40 agonist, was withdrawn from clinical development in Phase III due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5039027e87583ae398fb5cba3d8016cd
https://doi.org/10.2337/db21-124-lb
https://doi.org/10.2337/db21-124-lb
Autor:
Chorong Shin, Yearin Jun, Hyun-Jung Kwak, Jongmin Yoon, Seolhee Lee, In-Gyu Je, Eunhye Jang, Haengjin Song, Jung Ho Kim, Chang-Hee Hong, Dahae Hong, Jisu Kim, Hyo-Jung Song, Kyungmi An, Don-Gil Lee
Publikováno v:
Diabetes. 70
GPR40/FFAR1 is a G-protein-coupled receptor predominantly expressed in pancreatic β-cells. GPR40 agonists are known to stimulate insulin secretion and reduce circulating glucose levels in a glucose-dependent manner. Currently, IDG-16177, as a GPR40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3af04e0a0eaea2e801459ad5d987486e
https://doi.org/10.2337/db21-123-lb
https://doi.org/10.2337/db21-123-lb
Autor:
Matthew Smuck, Isabel Hyo Jung Song, Tahar Touati, Ruopeng Sun, U Khyoi Nu, Srushti Buddhadev
Publikováno v:
SSCI
Physical activity (PA) brings health benefits to adults. It is a crucial indicator of the general health condition, whether a person is physically active or not. This paper proposes ML (Machine Learning) -based PA classifiers to predict the individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27163bc567f100ac874fba00f2d80b4e
https://doi.org/10.1109/ssci47803.2020.9308353
https://doi.org/10.1109/ssci47803.2020.9308353
Autor:
Hyung Ho Yoon, Doo-Wan Cho, Sang Ryong Jeon, Young-Su Yang, Bo Ko Jang, Hyo Jung Song, C. Justin Lee, Sang-Wook Kim, Siwon Kim, Ki Duk Park, Su-Cheol Han, Jun Young Heo, Jong Hyun Park, Soo Jin Oh, Min-Ho Nam, Jiwon Choi
Background and PurposeMonoamine oxidase-B (MAO-B) is a long-standing therapeutic target for Parkinson’s disease (PD), however, previous clinical studies demonstrated discouraging effects of currently available irreversible MAO-B inhibitors. Since K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bfa6a9e87dc9284de3073dcf2318af8
https://doi.org/10.1101/2020.07.06.190579
https://doi.org/10.1101/2020.07.06.190579
